DRUG RELATED PROBLEM ASSOCIATED WITH THE TREATMENT FOR PULMONARY EDEMA, PNEUMONIA AND TYPE II DIABETES MELLITUS WITH GANGRENE DIABETICUM PEDIS DEXTRA IN PGI CIKINI HOSPITAL

Pulmonary edema is a condition cause by excess fluid in the lung. This fluid collect in the numerous air sacs in the lungs, making it difficult to breath. In most cases, heart problem can cause pulmonary edema. Pneumonia is a respiratory disease (lower respiratory tract (LRT) acute, usually caused by infection. Type II Diabetes Mellitus (DM) is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. Female, 48 year old, 65 kg and height 165 cm, was hospitalized with symptoms of wound in the right heel and pain about 1 month ago. Patient has a history of uncontrolled diabetes mellitus and allergy to neuralgin. Patient was diagnosed with pulmonary edema, pneumonia, type II diabetes mellitus with gangrene diabeticumpedisdextra. Patients has treated with Ceftriaxone injection 1 g, Lasix injection (Furosemide) 40 mg, valsartan 160 mg, Glurenorm (Gliquidone), Calcium gluconate injection, Albumin 25%, Pujimin (Supplement), Metronidazole, and Pladogrel (Clopidogrel). Based on the result of the clinic secretariat at the ward of K in PGI Cikini Hospital, it could be concluded that there was DRPs (Drug Related Problems). However, it can be concluded that the therapy and treatment of patients was right, but there are some things that should be evaluated.

1.  UEU-Journal-14162-11_0078.pdf - 356 KB

• PENGARUH PERESEPAN ELEKTRONIK TERHADAP MUTU LAYANAN FARMASI DI RUMAH SAKIT �X� JAKARTA BARAT
• LAPORAN MAGANG; PENGELOLAAN PERBEKALAN FARMASI DI INSTALASI FARMASI RUMAH SAKIT PRATIWI (IBU & ANAK) KOTA TANGERANG TAHUN 2013
• GAMBARAN PENCATATAN DAN PELAPORAN PERBEKALAN FARMASI DI RUMAH SAKIT SIAGA RAYA
• ANALISIS PENGARUH PROFITABILITAS, UKURAN PERUSAHAAN, LEVERAGE DAN NILAI PERUSAHAAN TERHADAP PRAKTIK PERATAAN LABA (STUDI EMPIRIS : PADA PERUSAHAAN INDUSTRI FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE TAHUN 2008-2011)
• ANALISIS PENGARUH LEVERAGE, STRUKTUR MODAL DAN PROFITABILITAS TERHADAP PRICE EARNING RATIO (PER) PADA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2002-2008
• ANALISIS FAKTOR � FAKTOR YANG MEMPENGARUHI STRUKTUR MODAL PADA PERUSAHAAN FARMASI DI BURSA EFEK INDONESIA (PERIODE 2006 � 2009)
• HUBUNGAN ANTARA MOTIVASI KERJA DAN KINERJA PETUGAS PELAYANAN RESEP OBAT JADI DI INSTALASI FARMASI RSUD CENGKARENG
• ANALISA PENGARUH PROFITABILITAS, TOTAL ASSET, INVENTORY TURNOVER, FINANCIAL LEVERAGE DAN OPINI AUDITOR TERHADAP PRAKTIK PERATAAN LABA PADA PERUSAHAAN FARMASI YANG TERDAFTAR DI BE1 PERIODE TAHUN 2007 - 2010
• GAMBARAN UMUM SISTEM MANAJEMEN LOGISTIK FARMASI DI RUMAH SAKIT ASSHOBIRIN TANGERANG TAHUN 2013
• PENATALAKSANAAN PENYIMPANAN FARMASI DI INSTALASI FARMASI RUMAH SAKIT MEDIKA PERMATA HIJAU JAKARTA BARAT